{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:07:38Z","timestamp":1786118858450,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1097\/nrl.0b013e31815a9945","type":"journal-article","created":{"date-parts":[[2008,7,3]],"date-time":"2008-07-03T03:06:18Z","timestamp":1215054378000},"page":"243-246","source":"Crossref","is-referenced-by-count":21,"title":["The Promise and Potential Pitfalls of Serum Biomarkers for Ischemic Stroke and Transient Ischemic Attack"],"prefix":"10.1097","volume":"14","author":[{"given":"Matthew B.","family":"Jensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus R.","family":"Chacon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin A.","family":"Sattin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aitziber","family":"Aleu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick D.","family":"Lyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210211","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1373\/49.10.1733","article-title":"Early biomarkers of stroke.","volume":"49","author":"Reynolds","year":"2003","journal-title":"Clin Chem"},{"key":"R2-4-20210211","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0361-9230(03)00089-3","article-title":"Protein s-100b, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients.","volume":"61","author":"Lamers","year":"2003","journal-title":"Brain Res Bull"},{"key":"R3-4-20210211","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/01.STR.0000105927.62344.4C","article-title":"Novel diagnostic test for acute stroke.","volume":"35","author":"Lynch","year":"2004","journal-title":"Stroke"},{"key":"R4-4-20210211","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1161\/01.STR.28.10.1956","article-title":"S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke.","volume":"28","author":"Missler","year":"1997","journal-title":"Stroke"},{"key":"R5-4-20210211","first-page":"239","article-title":"Study of serum and cerebrospinal fluid enzymes in diagnosis and differential diagnosis of cerebrovascular diseases.","volume":"39","author":"Ruzak-Skocir","year":"1990","journal-title":"Neurologija"},{"key":"R6-4-20210211","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/01.STR.25.2.282","article-title":"Hemostatic markers in acute transient ischemic attacks.","volume":"25","author":"Fon","year":"1994","journal-title":"Stroke"},{"key":"R7-4-20210211","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/01.STR.32.1.133","article-title":"Prognostic influence of increased c-reactive protein and fibrinogen levels in ischemic stroke.","volume":"32","author":"Di Napoli","year":"2001","journal-title":"Stroke"},{"key":"R8-4-20210211","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1161\/01.CIR.101.7.744","article-title":"Hyperfibrinogenemia is associated with specific histocytological composition and complications of atherosclerotic carotid plaques in patients affected by transient ischemic attacks.","volume":"101","author":"Mauriello","year":"2000","journal-title":"Circulation"},{"key":"R9-4-20210211","doi-asserted-by":"crossref","first-page":"956","DOI":"10.7326\/0003-4819-118-12-199306150-00008","article-title":"Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature.","volume":"118","author":"Ernst","year":"1993","journal-title":"Ann Intern Med"},{"key":"R10-4-20210211","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.jcbfm.9600264","article-title":"Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study.","volume":"26","author":"Tang","year":"2006","journal-title":"J Cereb Blood Flow Metab"},{"key":"R11-4-20210211","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1161\/01.STR.0000089920.93927.A7","article-title":"C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease.","volume":"34","author":"Arenillas","year":"2003","journal-title":"Stroke"},{"key":"R12-4-20210211","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1378\/chest.126.4.1032","article-title":"Risk stratification and prognostic implication of plasma biomarkers in nondiabetic patients with stable coronary artery disease: the role of high-sensitivity c-reactive protein.","volume":"126","author":"Leu","year":"2004","journal-title":"Chest"},{"key":"R13-4-20210211","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1161\/01.STR.0000165929.78756.ed","article-title":"Evaluation of c-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the crp pooling project members.","volume":"36","author":"Di Napoli","year":"2005","journal-title":"Stroke"},{"key":"R14-4-20210211","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1161\/hs1101.098151","article-title":"Plasma concentration of c-reactive protein and risk of ischemic stroke and transient ischemic attack: the framingham study.","volume":"32","author":"Rost","year":"2001","journal-title":"Stroke"},{"key":"R15-4-20210211","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1161\/01.CIR.0000065228.20100.F7","article-title":"C-reactive protein and the future risk of thromboembolic stroke in healthy men.","volume":"107","author":"Curb","year":"2003","journal-title":"Circulation"},{"key":"R16-4-20210211","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1468-1331.2006.01280.x","article-title":"Inflammatory biomarkers in blood of patients with acute brain ischemia.","volume":"13","author":"Sotgiu","year":"2006","journal-title":"Eur J Neurol"},{"key":"R17-4-20210211","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1161\/01.STR.27.9.1553","article-title":"Serial measurement of interleukin-6, transforming growth factor-\u03b2, and s-100 protein in patients with acute stroke.","volume":"27","author":"Kim","year":"1996","journal-title":"Stroke"},{"key":"R18-4-20210211","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/jama.293.13.1609","article-title":"N-terminal pro-brain natriuretic peptide, c-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.","volume":"293","author":"Kistorp","year":"2005","journal-title":"JAMA"},{"key":"R19-4-20210211","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1161\/01.STR.0000014922.83673.86","article-title":"Multiple panel of biomarkers for tia\/stroke evaluation.","volume":"33","author":"Dambinova","year":"2002","journal-title":"Stroke"},{"key":"R20-4-20210211","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1161\/01.STR.26.5.795","article-title":"Plasma homocysteine in the acute and convalescent phases after stroke.","volume":"26","author":"Lindgren","year":"1995","journal-title":"Stroke"},{"key":"R21-4-20210211","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1161\/01.STR.32.8.1701","article-title":"\u03b22-glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart program.","volume":"32","author":"Brey","year":"2001","journal-title":"Stroke"},{"key":"R22-4-20210211","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1373\/49.4.562","article-title":"Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke.","volume":"49","author":"Rainer","year":"2003","journal-title":"Clin Chem"},{"key":"R23-4-20210211","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1373\/49.10.1752","article-title":"Blood test detecting autoantibodies to N-methyl-d-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke.","volume":"49","author":"Dambinova","year":"2003","journal-title":"Clin Chem"},{"key":"R24-4-20210211","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1373\/clinchem.2005.053942","article-title":"Park7 and nucleoside diphosphate kinase a as plasma markers for the early diagnosis of stroke.","volume":"51","author":"Allard","year":"2005","journal-title":"Clin Chem"},{"key":"R25-4-20210211","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1074\/mcp.M300066-MCP200","article-title":"Fatty acid binding protein as a serum marker for the early diagnosis of stroke: a pilot study.","volume":"3","author":"Zimmermann-Ivol","year":"2004","journal-title":"Mol Cell Proteomics"},{"key":"R26-4-20210211","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1161\/01.STR.0000154878.58398.14","article-title":"Soluble cd40l and cardiovascular risk in asymptomatic low-grade carotid stenosis.","volume":"36","author":"Novo","year":"2005","journal-title":"Stroke"},{"key":"R27-4-20210211","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000089935","article-title":"Chitotriosidase in patients with acute ischemic stroke.","volume":"54","author":"Sotgiu","year":"2005","journal-title":"Eur Neurol"},{"key":"R28-4-20210211","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.jacc.2005.11.086","article-title":"Pregnancy-associated plasma protein-a is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques: a link between inflammation and cerebrovascular events.","volume":"47","author":"Sangiorgi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R29-4-20210211","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/01.CIR.0000154553.12214.CD","article-title":"Lipoprotein-associated phospholipase a2 activity is associated with risk of coronary heart disease and ischemic stroke: the rotterdam study.","volume":"111","author":"Oei","year":"2005","journal-title":"Circulation"},{"key":"R30-4-20210211","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000091537","article-title":"Apolipoproteins as predictors of ischaemic stroke in patients with a previous transient ischaemic attack.","volume":"21","author":"Bhatia","year":"2006","journal-title":"Cerebrovasc Dis"},{"key":"R31-4-20210211","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1161\/01.STR.26.10.1841","article-title":"Lipoprotein (a) serum concentration and apolipoprotein (a) phenotype correlate with severity and presence of ischemic cerebrovascular disease.","volume":"26","author":"Jurgens","year":"1995","journal-title":"Stroke"},{"key":"R32-4-20210211","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1161\/01.STR.31.7.1521","article-title":"Chlamydia pneumoniae and the risk of first ischemic stroke: the Northern Manhattan stroke study.","volume":"31","author":"Elkind","year":"2000","journal-title":"Stroke"},{"key":"R33-4-20210211","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/01.STR.29.2.404","article-title":"Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham stroke project.","volume":"29","author":"Cook","year":"1998","journal-title":"Stroke"},{"key":"R34-4-20210211","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1161\/01.STR.31.8.1863","article-title":"Serial measurement of vascular endothelial growth factor and transforming growth factor-\u03b21 in serum of patients with acute ischemic stroke.","volume":"31","author":"Slevin","year":"2000","journal-title":"Stroke"},{"key":"R35-4-20210211","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1161\/01.STR.29.9.1882","article-title":"The apolipoprotein e \u03b54 allele and outcome in cerebrovascular disease.","volume":"29","author":"McCarron","year":"1998","journal-title":"Stroke"},{"key":"R36-4-20210211","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.STR.0000117575.48205.2D","article-title":"Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack: the Framingham cohort and offspring study.","volume":"35","author":"Janardhan","year":"2004","journal-title":"Stroke"}],"container-title":["The Neurologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/NRL.0b013e31815a9945","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:10:08Z","timestamp":1786036208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00127893-200807000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/nrl.0b013e31815a9945","relation":{},"ISSN":["1074-7931"],"issn-type":[{"value":"1074-7931","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}